åãæéã«VAERSãåãã€ããäºæ
ã¬ããŒãã¯6994件ã§ãã£ãã
ãã®ãã¡6354件ïŒ90.8%ïŒã¯è»œåºŠã®å¯äœçšã®å ±åã§ã
çç¶ãšããŠã¯é çïŒ22.4%ïŒ
åŠæ æïŒ16.4%ïŒ
ããŸãïŒ16.5%ïŒ
ã®é ã«å€ãã£ãã
ãŸãå¯äœçšã®å ±åã¯2åç®ã®æ¥çš®åŸã«ææã«é«ãåŸåãèŠãããããããã¯æéå ã«2床ç®ã®æ¥çš®ãçµããŠããPfizer-BioNTechã ãã«é¢ããçµæã§ãModernaã«ã€ããŠã¯ãŸã 2床ç®ã®æ¥çš®ãçµãã£ãŠããªããããä»åã¯ããŒã¿ããªãã
æ·±å»ãªå¯äœçšã®å ±åã
640件ïŒ9.2%ïŒãããã¢ããã£ã©ãã·ãŒã¯
100äžæ¥çš®ããã4.5件ã®çºçé »åºŠã§ãã£ãã
ãã®ãã¡6354件ïŒ90.8%ïŒã¯è»œåºŠã®å¯äœçšã®å ±åã§ã
çç¶ãšããŠã¯é çïŒ22.4%ïŒ
åŠæ æïŒ16.4%ïŒ
ããŸãïŒ16.5%ïŒ
ã®é ã«å€ãã£ãã
ãŸãå¯äœçšã®å ±åã¯2åç®ã®æ¥çš®åŸã«ææã«é«ãåŸåãèŠãããããããã¯æéå ã«2床ç®ã®æ¥çš®ãçµããŠããPfizer-BioNTechã ãã«é¢ããçµæã§ãModernaã«ã€ããŠã¯ãŸã 2床ç®ã®æ¥çš®ãçµãã£ãŠããªããããä»åã¯ããŒã¿ããªãã
æ·±å»ãªå¯äœçšã®å ±åã
640件ïŒ9.2%ïŒãããã¢ããã£ã©ãã·ãŒã¯
100äžæ¥çš®ããã4.5件ã®çºçé »åºŠã§ãã£ãã